3Kristóf K,Kocsis E,Nagy K.Clinical microbiology of early-onset and late-onset neonatal sepsis,particularly among preterm babies[J].Acta Microbiol Immunol Hung,2009,56(1):21-51.
4Zuppa A A,Calabrese V,D'Andrea V,et al.Evaluation of C reactive protein and others immunologic markers in the diagnosis of neonatal sepsis[J].Minerva Pediatr,2007,59(3):267-274.
5Ramirez-Valdivia J M,Pérez-Molina J J,Locheo-González M,et al.Procalcitonin a marker in the diagnostic of the newborn with systemic infection[J].Rev Med Inst Mex Seguro Soc,2008,46(6):597-602.
6Sasaki K,Fujita I,Hamasaki Y,et al.Differentiating between bacterial and viral infection by measuring both C-reactive protein and 2'-5'-oligoadenylate synthetase as inflammatory markers[J].J Infect Chemother,2002,8 (1):76-80.
7Martin G S,Mannino D M,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000[J].N Engl J Med,2003,348(16):1546-1554.
8Whang KT, Vath SD, Becker KL, et al. Procalcitonin and pro-inflammatory cytokine interactions in sepsis [ J]. Shock,2000,14(1): 73-78.
9Nijsten MW, Olinga P, The TH,et al. Procalcitonin behaves as a fastresponding acute phase protein in vivo and in vitro [ J]. Crit Care Med, 2000, 28 (2): 458461.
10Wiedermann FJ,Kaneider N,Egger P, et al. Migration of human monocytes in response to procalcitonin [J]. Crit Care Med, 2002 , 30(5): 1112-1117.
